TORONTO – May 29, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company’s subsidiary, Alternate Medical Media (“AMM”), has sold over 30 group education packages of its CBD Certification programs since launching institutional sales on March 30, 2019.

“We are excited to build new relationships within the international cannabis and hemp community as we establish AMM as the authority in online CBD education,” says Howard Mann, CEO of Alternate Health. “Growth in our education division offers potential opportunities with our Company’s other businesses, including hemp extraction and product development and distribution.”

Alternate Medical Media’s programs are powered by the Company’s proprietary online Learning Management System (LMS). Alternate Medical Media originally offered Continuing Medical Education (CME) modules for physicians. Since then AMM ‘s courses have evolved, focusing on businesses and the general public, based on strong demand for information on cannabinoids and the endocannabinoid system.

Currently, AMM offers two complete Certification Programs:

  • CBD Only: Course for healthcare professionals, medical cannabis patients, CBD industry professionals and the general public.
  • CBD & THC: Course for dispensary operators, cannabis industry professionals and medical cannabis patients.

Alternate Medical Media’s customer base is growing, primarily with interest from CBD companies and dispensary networks looking to train and educate their employees. Each CBD course includes interactive features to reinforce and evaluate employee knowledge retention. AMM also offers customizable options for large enterprises, including branded homepage access and company portals.

“We offer a scalable, in-depth program that is perfect training for people working in the CBD and cannabis industry,” says Rick Anderson, Managing Director of Alternate Medical Media. “Our education programs are also effective in spreading awareness of Alternate Health’s expertise not only in software, but also in cannabinoid research and development.”


The Company would also like to announce the resignation of George Mull as President and Company Director as part of its move away from adult-use cannabis to focus exclusively on CBD products. In conjunction with the Company’s change in focus, Alternate Health and George Mull have decided not to move forward with the Four Twenty Inc. acquisition agreement previously announced on October 17, 2018. George Mull will retain ownership of Four Twenty Inc. and its related licensed entity. George Mull will reimburse Alternate Health for certain financial expenditures and abandon any claim to the 1,000,000 warrants for Alternate Health common stock issued under the agreement, returning them to the treasury.

“I am excited and honored to commence operations within the incredibly talented and dedicated cannabis community of Humboldt County,” says George Mull. “We will be happy to provide products and assistance to Alternate Health, should the company decide to reenter the cannabis market. I wish Alternate Health all the best as it moves in its new direction.”


Alternate Health (CSE: AHG, OTCQB: AHGIF) is an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health recently announced that it is acquiring Blaine Labs Inc., a Company that is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s industry-leading software systems provide the platform for the Company’s diverse operations, including hemp-derived extract manufacturing, CBD product distribution, blockchain tax collection systems and electronic medical records (EMR) systems.

Alternate Health’s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders.

For more information about Alternate Health Corp., visit


Jim Griffiths | Investor Relations

Jim Tykoliz | Company Director


Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations, business prospects, anticipated growth and potential revenues are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.